Introduction
Pivampicillin is a commonly used antibiotic in the therapy of puerperal infections. In humans pivampicillin is almost completely transformed into ampicillin which is the biologically active component. To our knowledge, only one investigation has determined the amount of an ampicillin excreted in human milk [1] . Several reports on concentrations of ampicillin in milk from animals have been published [7, 8] . The object of the present study was to determine the levels of ampicillin in blood and milk of mothers in therapy with pivampicillin and in the blood of their suckling infants thereby estimating the dose a neonate may receive. Also, we have analyzed blood and milk samples from 4 mothers for a longer period in an attempt to find a time when levels in plasma and milk reached an equilibrium. Finally, we have calculated the milk-plasma (M/P) ratio and the degree of protein binding of ampicillin in milk.
Material and methods
Fourteen mothers with puerperal infections requiring antibiotic treatment gave informed consent to participate. Nine mothers receiving pivampicillin tablets 350 mg t. d. s. had blood sampled 2 and 4 hours after the last tablet and at breast feeding. Three mothers receiving pivampicillin tablets 350 mg t. d. s. and two mothers receiving 700 mg t.d. s. had blood sampled immediately before medication and then every half hour for 2 hours and every one hour for 4 to 6 hours after medication. Milk samples were collected during feeding. One hour later a blood sample was drawn from the infants.
Medication was started from 0 to 22 days after parturition and no sample collected until at least 24 hours after start of pivampicillin therapy. All mothers received metronidazole tablets 200 mg t. d. s. during the test period, but no other medication.
All samples were analyzed by microbiologic method [2] , the lower limit of detection being 0.03 g/ml. The test bacteria were not sensitive to metronidazole. A non-specific antibiotic inhibition was observed in the milk, but it was eliminated by dilution.
Ampicillin was added to four milk samples from non-medicated mothers. Two concentrations, i. e. 0.3 g/ml and 3 g/ml, were used and levels in the ultra filtrate were measured. The amount of recovered free antibiotic was then determined.
When the study was commenced, no ethical committee was operative in the area.
Results
Concentrations of ampicillin in blood and milk from 9 mothers are shown in table I. Concentrations from 5 mothers, who had samples collected for a longer period, are shown in table II.
No antibacterial activity was observed in any of the infant blood samples, i.e. all samples contained less than 0.03 g ampicillin per ml blood. Maximum concentrations in plasma are reached 60 to 120 minutes after oral intake of pivampicillin. In milk, maximum levels are reached 180 to 240 minutes after medication. There is most likely a significant delay before a balance between levels in blood and milk is reached. This delay is estimated to be 100 to 180 minutes. When the balance is obtained, levels in milk seem to vary very little.
The milk-plasma (M/P) ratio is normally calculated on the basis of simultaneous samples from blood and milk. Such a calculation gives a wide range, i. e. 0.01-0.58, of M/P values (table I) .
The recovery rate of ampicillin in the ultra filtrate was 94 to 105%. As the variance of analysis with this method is 5 -10%, ampicillin is found not to be bound to protein in human milk.
Discussion
Administration of drugs to lactating mothers always raises the question of a possible harmful effect of the drug on the suckling infant. The excretion of drugs from plasma to milk is by most believed to take place by passive diffusion controlled by the difference in plasma and milk pH and by protein binding in plasma and milk [3] . Drugs, which have a high degree of protein binding in plasma, have been shown not to pass into milk [4] . Drugs, which are neutrally reacting or with a small molecular weight, pass freely into milk and are found in equal concentrations in plasma and milk [4] .
Most drugs are either weak acids or weak bases.
As pH in milk is 6.85 and in plasma 7.4, weak bases will concentrate in milk and weak acids will occur in lower concentrations than in plasma [3] .
Ampicillin is an ampholyte with two pKa values, 2.7 and 7.2 at pH 7.O. As a consequence it will mainly be acting as a weak acid and the significant pKa value will be 2.7. Using a modification of the Hasselbalch-Henderson equation [3] and with pH for milk and plasma being 6.85 and 7.4, respectively, M/P ratio can be calculated to be 0.28.
The basis for the above calculation is an equilibrium between milk and plasma levels. This is not From our findings that the ampicillin protein binding in milk is 0 and the one in plasma is reported to be 18% [4] , the M/P ratio must be reduced to 0.23. The discrepancy with our result of an M/P ratio at 0.10 (average of M/P values in table I) is probably due to the fact that an equilibrium is never obtained because of decreasing levels of ampicillin in plasma. From the only previous report on ampicillin excretion in human milk [1] can be found M/P ratios varying between 0.02 and 3.0 with a mean of 0.3. Dosage was 500 mg ampicillin every 6 hours and milk and blood were sampled simultaneously. M/P ratios reported for other penicillins are in accordance with our findings [6] .
The daily maximum ampicillin dose an infant has received from a mother in the present study assuming a milk consumption of 500 ml per day has been 500 ml 1.02 ^g/ml = 0.5 mg (table II) . This amount is insignificant and cannot explain reported incidents of diarrhoea and candidiasis in suckling infants whose mothers received ampicillin [5] .
Allergic erythema has not been reported in suckling infants, but sensibilization even with a low dose of ampicillin is possible and should be kept in mind.
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